Article Versions Notes

Linnekamp JF, Kandimalla R, Fessler E, de Jong JH, Rodermond HM, van Bochove GGW, The FO, Punt CJA, Bemelman WA, van de Ven AWH, et al. Pre-Operative Decitabine in Colon Cancer Patients: Analyses on WNT Target Methylation and Expression. Cancers. 2021; 13(10):2357. https://doi.org/10.3390/cancers13102357

Linnekamp, Janneke F., Raju Kandimalla, Evelyn Fessler, Joan H. de Jong, Hans M. Rodermond, Gregor G. W. van Bochove, Frans O. The, Cornelis J. A. Punt, Willem A. Bemelman, Anthony W. H. van de Ven, and et al. 2021. "Pre-Operative Decitabine in Colon Cancer Patients: Analyses on WNT Target Methylation and Expression" Cancers 13, no. 10: 2357. https://doi.org/10.3390/cancers13102357

Linnekamp, J. F., Kandimalla, R., Fessler, E., de Jong, J. H., Rodermond, H. M., van Bochove, G. G. W., The, F. O., Punt, C. J. A., Bemelman, W. A., van de Ven, A. W. H., Tanis, P. J., Kemper, E. M., Koens, L., Dekker, E., Vermeulen, L., van Laarhoven, H. W. M., & Medema, J. P. (2021). Pre-Operative Decitabine in Colon Cancer Patients: Analyses on WNT Target Methylation and Expression. Cancers, 13(10), 2357. https://doi.org/10.3390/cancers13102357